Researchers Have Found New Causes of Angiosarcoma and 3 Trials are Underway
source: pixabay.com

Researchers Have Found New Causes of Angiosarcoma and 3 Trials are Underway

Angiosarcoma Angiosarcoma is a rare condition caused by a tumor within the endothelial cells. These cells line the blood vessels in the body, and therefore the tumors can occur practically…

Continue Reading Researchers Have Found New Causes of Angiosarcoma and 3 Trials are Underway
Neurogene and Behind the Seizure Work to Provide Better Diagnostics for Batten Disease
source: pixabay.com

Neurogene and Behind the Seizure Work to Provide Better Diagnostics for Batten Disease

Neurogene, which works to provide treatments for rare neurological disorders, has recently joined with Behind the Seizure. Behind the Seizure was established by two other companies, BioMarin and Invitae, with…

Continue Reading Neurogene and Behind the Seizure Work to Provide Better Diagnostics for Batten Disease
Experimental CAR NK-Cell Therapy Produces Results in Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphona
source: pixabay.com

Experimental CAR NK-Cell Therapy Produces Results in Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphona

According to a story from Targeted Oncology, a recent phase 1/2a clinical trial of an experimental treatment called TAK-007 produced a clinical response in the majority of patients in the…

Continue Reading Experimental CAR NK-Cell Therapy Produces Results in Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphona
Study Tracks Survival, Quality of Life, and Follow up for Lambert-Eaton Myasthenic Syndrome Patients
source: pixabay.com

Study Tracks Survival, Quality of Life, and Follow up for Lambert-Eaton Myasthenic Syndrome Patients

According to a study published in the scientific journal Neurology, the survival rates of patients with Lambert-Eaton myasthenic syndrome (LEMS) were compared to that of the general population as well as…

Continue Reading Study Tracks Survival, Quality of Life, and Follow up for Lambert-Eaton Myasthenic Syndrome Patients
An In-Depth Look at the European Medicines Agency’s Orphan Drug Designation Post-Brexit
source: pixabay.com

An In-Depth Look at the European Medicines Agency’s Orphan Drug Designation Post-Brexit

  On February 3, 2020, twenty-seven newly installed flags of the European Union stood in the gleaming lobby of the new European Medicines Agency (EMA) headquarters in Amsterdam. The Charcot-Marie-Tooth…

Continue Reading An In-Depth Look at the European Medicines Agency’s Orphan Drug Designation Post-Brexit
The Muscular Dystrophy Association Steps up for Rare Neuromuscular Diseases
source: pixabay.com

The Muscular Dystrophy Association Steps up for Rare Neuromuscular Diseases

According to a story from Charcot-Marie-Tooth News, the Muscular Dystrophy Association (MDA) may at first seem like a group that is solely focused on helping muscular dystrophy patients, but its…

Continue Reading The Muscular Dystrophy Association Steps up for Rare Neuromuscular Diseases
Expanding AAV Manufacturing Capacity is Essential to Our Ability to Cure More Patients Living with Rare Disease
source: pixabay.com

Expanding AAV Manufacturing Capacity is Essential to Our Ability to Cure More Patients Living with Rare Disease

  The National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) and the Center for Biologics Evaluation and Research (CBER) of the Food and Drug…

Continue Reading Expanding AAV Manufacturing Capacity is Essential to Our Ability to Cure More Patients Living with Rare Disease